Figure 2.
Receiver operating characteristic curve analysis showing the infliximab threshold that best discriminated disease activity, as measured by C-reactive protein (concentration ≤5 mg/L was defined as inactive disease).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.